Dennis S. Charney
Dennis S. Charney is an American
biological psychiatrist and
researcher, with expertise in the
neurobiology and treatment of
mood and
anxiety disorders. He is the author of ''Neurobiology of Mental Illness'', ''The Physician's Guide to Depression and Bipolar Disorders'' and ''Molecular Biology for the Clinician'', as well as the author of over 600 original papers and chapters. In 2022, he was listed #49 on
Research.com's "Top Medicine Scientists in the United States," with an
h-index of 218 with 173,960 citations across 887 publications. Charney is known for demonstrating that
ketamine is effective for treating depression. Ketamine's use as a rapidly-acting anti-depressant is recognized as a breakthrough treatment in mental illness.
He is a professor of
psychiatry, professor of
neuroscience and professor of
pharmacology and systems therapeutics at
Icahn School of Medicine at Mount Sinai in
New York City.
In 2007, he became the Dean of the School and Executive Vice President for Academic Affairs of what was then known as the Mount Sinai Medical Center. In 2013, he was named President of Academic Affairs for the
Mount Sinai Health System and as of 2024 still holds these roles. According to Becker's Hospital Review, he will be leaving his position as Dean of Icahn School of Medicine at Mount Sinai at the end of June, 2025.
Provided by Wikipedia